Table 3.
Class drug | Absorption | Distribution | Metabolism | Elimination | |
---|---|---|---|---|---|
mainly | |||||
NS3/4A Protease | substrate for | inhibitor or inducer | |||
Inhibitors | |||||
First-Wave | ↑ by food | PPB 75% | CYP3A4/5 | Moderate CYP3A | Hepatic |
Boceprevir | P-gp inhibitor | AKR | inhibitor | ||
Telaprevir | ↑ by fatty | PPB 60-76% | CYP3A4/5 | Strong CYP3A | Hepatic |
Moderate P-gp inhibitor | inhibitor | ||||
Second-Wave | ↑ by food | PPB 99% | CYP3A4 | mildly nhibits | Hepatic |
Simeprevir | inhibitor of P-gp, OATP1B1 and | intestinal CYP3A4 and | |||
MRP2 | CYP1A2 | ||||
Asunaprevir | ↑ by fatty meals | PPB 99% | CYP3A | Moderate inhibitor | Hepatic |
inhibitor of P-gp and OATP1B1 | of CYP2D6; weak | ||||
inducer of CYP3A4 | |||||
Paritaprevir | ↑ by food | PPB 97-98-% | CYP3A4/5 | ND | Hepatic |
substrate for P-gp and BCRP; | |||||
inhibitor of OATP1B1 | |||||
Grazoprevir | PPB 98.8% | CYP3A | Weak inhibitor of | Hepatic | |
↑ by fatty meals | Transported by OATP1B1, P-gp. | CYP3A | |||
Inhibits BCRP | |||||
NS5A Inhibitors | |||||
Daclatasvir | ↓ by fatty meals | PPB 99% | CYP3A | ND | Hepatic |
inhibitor of P-gp | |||||
and OATP1B1 | |||||
Ledipasvir | ↓ by increasing gastric | PPB 99% | Minimally | ND | as parent drug |
pH | substrate and an inhibitor of P-gp | metabolized | |||
Ombitasvir | ↑ by food | PPB 99% | Amide hydrolysis | ND | Hepatic |
substrate of P-gp and BCRP | |||||
Elbasvir | ↓ by fatty meals | PPB 99.9% | CYP3A | ND | Hepatic |
Transported by, P-gp. Inhibits | |||||
BCRP, P-gp | |||||
Velpatasvir | ↓ by fatty meals | PPB 99.5% | CYP2B6, | Hepatic | |
Transported by and inhibits | CYP2C8, | ||||
P-gp, BCRP, OATP1B1, | CYP3A4 | ||||
OATP1B3 | |||||
NS5B Polymerase Inhibitors | |||||
Nucleoside Inhibitors | |||||
Sofosbuvir | Food ↔ | PPB 61-65% | Prodrug is | ND | Renal |
Substrate of P-gp and BCRP | phosphorylated | ||||
to active-form | |||||
Non-Nucleoside Inhibitors | |||||
Dasabuvir | ↑ by food | PPB 99% | CYP2C8 | ND | Hepatic |
substrate of P-gp and BCRP | CYP3A, CYP2D6 |
AKR: aldo keto reductase; BCRP: breast cancer resistance protein; CYP: cytochrome P450; DAA: direct-acting antiviral agent; MRP: multidrug resistant protein; ND: no data; OATP: organic anion transporting polypeptide; P-gp: P-glycoprotein; PPB: plasma protein binding. ↑ increase; ↓ decrease; ↔ nil